Garvan Institute of Medical Research

46 items matching your search terms.

The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review: Wark, G.; Samocha-Bonet, D.; Ghaly, S.; Danta, M.; Nutrients 13 (1) 2020 10.3390/nu13010135

Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin: Htet, T. D.; Godneva, A.; Liu, Z.; Chalmers, E.; Kolobkov, D.; Snaith, J. R.; Richens, R.; Toth, K.; Danta, M.; Hng, T. M.; Elinav, E.; Segal, E.; Greenfield, J. R.; Samocha-Bonet, D.; BMJ Open 10 (10) :e037859, 2020 10.1136/bmjopen-2020-037859

Nutritional and metabolic regulation of the metabolite dimethylguanidino valeric acid: an early marker of cardiometabolic disease: Wali, J. A.; Koay, Y. C.; Chami, J.; Wood, C.; Corcilius, L.; Payne, R. J.; Rodionov, R. N.; Birkenfeld, A. L.; Samocha-Bonet, D.; Simpson, S. J.; O'Sullivan, J. F.; AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 319 (3) :E509-E518, 2020 10.1152/ajpendo.00207.2020

SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control: Montgomery, M. K.; Bayliss, J.; Devereux, C.; Bezawork-Geleta, A.; Roberts, D.; Huang, C.; Schittenhelm, R. B.; Ryan, A.; Townley, S. L.; Selth, L. A.; Biden, T. J.; Steinberg, G. R.; Samocha-Bonet, D.; Meex, R. C. R.; Watt, M. J.; Science Translational Medicine 12 (559) :eaaz8048, 2020 10.1126/scitranslmed.aaz8048

The effect of body acid-base state and manipulations on body glucose regulation in human: Chalmers, E.; Samocha-Bonet, D.; EUROPEAN JOURNAL OF CLINICAL NUTRITION 74 (Suppl 1) :20-26, 2020 10.1038/s41430-020-0692-6

Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose Tissue Carotenoid Concentrations in Adults: Harari, A.; Coster, A. C.; Jenkins, A.; Xu, A.; Greenfield, J. R.; Harats, D.; Shaish, A.; Samocha-Bonet, D. Currently E-PUB; JOURNAL OF NUTRITION 150 (1) :38-46, 2020 10.1093/jn/nxz184

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney disease: Milder, T. Y.; Stocker, S. L.; Samocha-Bonet, D.; Day, R. O.; Greenfield, J. R.; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 75 (11) :1481-1490, 2019 10.1007/s00228-019-02732-y

Longitudinal Changes in Insulin Resistance in Normal Weight, Overweight and Obese Individuals: Tang, A.; Coster, A. C. F.; Tonks, K. T.; Heilbronn, L. K.; Pocock, N.; Purtell, L.; Govendir, M.; Blythe, J.; Zhang, J.; Xu, A.; Chisholm, D. J.; Johnson, N. A.; Greenfield, J. R.; Samocha-Bonet, D.; Journal of Clinical Medicine 8 (5) :pii: E623, 2019 10.3390/jcm8050623

Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis: Milder, T. Y.; Stocker, S. L.; Abdel Shaheed, C.; McGrath-Cadell, L.; Samocha-Bonet, D.; Greenfield, J. R.; Day, R. O.; Journal of Clinical Medicine 8 (1) :pii: E45, 2019 10.3390/jcm8010045

Food Overconsumption in Healthy Adults Triggers Early and Sustained Increases in Serum Branched-Chain Amino Acids and Changes in Cysteine Linked to Fat Gain: Elshorbagy, A. K.; Samocha-Bonet, D.; Jerneren, F.; Turner, C.; Refsum, H.; Heilbronn, L. K.; JOURNAL OF NUTRITION 148 (7) :1073-1080, 2018 10.1093/jn/nxy062

Effects of Glutamine on Gastric Emptying of Low- and High-Nutrient Drinks in Healthy Young Subjects-Impact on Glycaemia: Du, Y. T.; Piscitelli, D.; Ahmad, S.; Trahair, L. G.; Greenfield, J. R.; Samocha-Bonet, D.; Rayner, C. K.; Horowitz, M.; Jones, K. L.; Nutrients 10 (6) :E739, 2018 10.3390/nu10060739

Prevention and Treatment of Type 2 Diabetes: A Pathophysiological-Based Approach: Samocha-Bonet, D.; Debs, S.; Greenfield, J. R.; TRENDS IN ENDOCRINOLOGY AND METABOLISM :pii: S1043-2760(18)30059-6, 2018 10.1016/j.tem.2018.03.014

Complex interplay among adiposity, insulin resistance and bone health: Ma, C.; Tonks, K. T.; Center, J. R.; Samocha-Bonet, D.; Greenfield, J. R.; Clin Obes 8 (2) :131-139, 2018 10.1111/cob.12240

Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance: Fazakerley, D. J.; Chaudhuri, R.; Yang, P.; Maghzal, G. J.; Thomas, K. C.; Krycer, J. R.; Humphrey, S. J.; Parker, B. L.; Fisher-Wellman, K. H.; Meoli, C. C.; Hoffman, N. J.; Diskin, C.; Burchfield, J. G.; Cowley, M. J.; Kaplan, W.; Modrusan, Z.; Kolumam, G.; Yang, J. Y.; Chen, D. L.; Samocha-Bonet, D.; Greenfield, J. R.; Hoehn, K. L.; Stocker, R.; James, D. E.; eLife 7 :pii: e32111, 2018 10.7554/eLife.32111